首页 > 最新文献

Gynecologic and Obstetric Investigation最新文献

英文 中文
A Predictive Model for Treatment Effectiveness in Severe Primary Immune Thrombocytopenia during Pregnancy: A Retrospective Study in a Tertiary Critical Maternity Referral Center. 妊娠期严重原发性免疫血小板减少症治疗效果的预测模型:一家三级危重孕产妇转诊中心的回顾性研究。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-05 DOI: 10.1159/000541721
Chuan Wang, Zhihong He, Ka U Lio, Haoting Shi, Jieying Wang, Yu Zhang, Ning Zhang

Objectives: The study aimed to identify factors influencing the severity of primary immune thrombocytopenia (ITP) during pregnancy, develop a predictive model for treatment response, and report maternal and neonatal outcomes associated with severe ITP.

Design: A retrospective analysis was conducted on 155 pregnancies with severe ITP between January 2018 and April 2023 at a tertiary critical maternity referral center in Shanghai, China. Participants/Materials: The study included 155 pregnancies diagnosed with severe ITP, divided into groups based on the lowest platelet count (<30 × 109/L vs. 30-50 × 109/L) and first-line treatment response (non-response vs. response).

Setting: The study was conducted at Renji Hospital, Shanghai Jiao Tong University School of Medicine, a tertiary critical maternity rescue referral center.

Methods: Clinical characteristics and outcomes were compared between groups. A multivariable logistic regression model was used to identify factors associated with the severity of ITP. A prediction model for treatment response was established using LASSO-logistic regression and internally validated.

Results: ITP severity was found to be correlated with low maximum amplitude of thromboelastography (OR 5.43, 95% CI: 1.48-16.00, p = 0.002), bleeding events (OR 4.91, 95% CI: 1.62-14.86, p = 0.005), and low reticulocytes (OR 2.40 × 10-7, 95% CI: 1.06 × 10-13 to 0.55, p = 0.04). Of the 118 patients who received first-line therapy, 52 (44%) responded. The dataset was randomly split into a training (N = 99) and test (N = 23) set with a ratio of 8:2. A predictive nomogram was created and internally validated showing good discrimination. The model yielded an area under receiver operating characteristic curve of 0.78 (0.69-0.87) and 0.85 (0.67-1.00) in the training and validation cohort, respectively. Earlier delivery and high rate of neonatal intensive care unit admission occurred with severe ITP and treatment failure.

Limitations: The study was limited by a relatively small sample size and the retrospective observational design, which imposed limitations on the assessment of treatment efficacy.

Conclusions: We identified clinical predictors of ITP severity and treatment resistance during pregnancy. A nomogram predicting first-line response was validated. These findings can facilitate clinical decision-making and counseling regarding this challenging pregnancy complication.

目的 该研究旨在确定影响妊娠期原发性免疫性血小板减少症(ITP)严重程度的因素,建立治疗反应预测模型,并报告与严重ITP相关的孕产妇和新生儿结局。设计 在中国上海的一家三级危重孕产妇转诊中心,对2018年1月至2023年4月期间155例重症ITP孕妇进行了回顾性分析。参与者/材料 该研究纳入了155例确诊为重症ITP的孕妇,根据最低血小板计数(<30×109/L vs. 30-50×109/L)和一线治疗反应(无反应 vs. 有反应)将其分为几组。研究地点 上海交通大学医学院附属仁济医院是一家三级危重孕产妇抢救转诊中心。方法 比较两组患者的临床特征和预后。采用多变量逻辑回归模型确定与 ITP 严重程度相关的因素。采用 LASSO 逻辑回归法建立了治疗反应预测模型,并进行了内部验证。结果 发现 ITP 严重程度与血栓弹力图(TEG)最大振幅(MA)低(OR 5.43,95% CI 1.48 至 16.00,p=0.002)、出血事件(OR 4.91,95% CI 1.62 至 14.86,p=0.005)和网状细胞低(OR 2.40×10-7,95% CI 1.06×10-13 至 0.55,p=0.04)相关。在接受一线治疗的 118 名患者中,有 52 人(44%)做出了反应。数据集以 8:2 的比例随机分为训练集(N=99)和测试集(N=23)。创建了一个预测提名图,并进行了内部验证,显示出良好的区分度。在训练组和验证组中,该模型的接收者操作特征曲线下面积(ROC)分别为 0.78(0.69 至 0.87)和 0.85(0.67 至 1.00)。严重的ITP和治疗失败会导致提早分娩和高NICU入院率。局限性 本研究受限于相对较小的样本量和回顾性观察设计,这对疗效评估造成了限制。结论 我们确定了妊娠期 ITP 严重程度和耐药性的临床预测因素。预测一线反应的提名图得到了验证。这些发现有助于针对这一具有挑战性的妊娠并发症做出临床决策和提供咨询服务。
{"title":"A Predictive Model for Treatment Effectiveness in Severe Primary Immune Thrombocytopenia during Pregnancy: A Retrospective Study in a Tertiary Critical Maternity Referral Center.","authors":"Chuan Wang, Zhihong He, Ka U Lio, Haoting Shi, Jieying Wang, Yu Zhang, Ning Zhang","doi":"10.1159/000541721","DOIUrl":"10.1159/000541721","url":null,"abstract":"<p><strong>Objectives: </strong>The study aimed to identify factors influencing the severity of primary immune thrombocytopenia (ITP) during pregnancy, develop a predictive model for treatment response, and report maternal and neonatal outcomes associated with severe ITP.</p><p><strong>Design: </strong>A retrospective analysis was conducted on 155 pregnancies with severe ITP between January 2018 and April 2023 at a tertiary critical maternity referral center in Shanghai, China. Participants/Materials: The study included 155 pregnancies diagnosed with severe ITP, divided into groups based on the lowest platelet count (<30 × 109/L vs. 30-50 × 109/L) and first-line treatment response (non-response vs. response).</p><p><strong>Setting: </strong>The study was conducted at Renji Hospital, Shanghai Jiao Tong University School of Medicine, a tertiary critical maternity rescue referral center.</p><p><strong>Methods: </strong>Clinical characteristics and outcomes were compared between groups. A multivariable logistic regression model was used to identify factors associated with the severity of ITP. A prediction model for treatment response was established using LASSO-logistic regression and internally validated.</p><p><strong>Results: </strong>ITP severity was found to be correlated with low maximum amplitude of thromboelastography (OR 5.43, 95% CI: 1.48-16.00, p = 0.002), bleeding events (OR 4.91, 95% CI: 1.62-14.86, p = 0.005), and low reticulocytes (OR 2.40 × 10-7, 95% CI: 1.06 × 10-13 to 0.55, p = 0.04). Of the 118 patients who received first-line therapy, 52 (44%) responded. The dataset was randomly split into a training (N = 99) and test (N = 23) set with a ratio of 8:2. A predictive nomogram was created and internally validated showing good discrimination. The model yielded an area under receiver operating characteristic curve of 0.78 (0.69-0.87) and 0.85 (0.67-1.00) in the training and validation cohort, respectively. Earlier delivery and high rate of neonatal intensive care unit admission occurred with severe ITP and treatment failure.</p><p><strong>Limitations: </strong>The study was limited by a relatively small sample size and the retrospective observational design, which imposed limitations on the assessment of treatment efficacy.</p><p><strong>Conclusions: </strong>We identified clinical predictors of ITP severity and treatment resistance during pregnancy. A nomogram predicting first-line response was validated. These findings can facilitate clinical decision-making and counseling regarding this challenging pregnancy complication.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"1-12"},"PeriodicalIF":2.0,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142380703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trustworthiness Criteria for Meta-Analyses of Randomized Controlled Studies: OBGYN Journal Guidelines. 随机对照研究荟萃分析的可信度标准:妇产科杂志指南》。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-03 DOI: 10.1159/000541479
{"title":"Trustworthiness Criteria for Meta-Analyses of Randomized Controlled Studies: OBGYN Journal Guidelines.","authors":"","doi":"10.1159/000541479","DOIUrl":"10.1159/000541479","url":null,"abstract":"","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"1-5"},"PeriodicalIF":2.0,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142371702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oocyte Quality in Women with Endometriosis. 子宫内膜异位症妇女的卵母细胞质量。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-30 DOI: 10.1159/000541615
Rafael Trinchant, Juan Antonio García-Velasco

Background: Endometriosis is a chronic gynecological condition that affects approximately 10% of women of reproductive age globally. It is associated with significant morbidity due to symptoms such as pelvic pain and infertility. Current knowledge suggests that endometriosis impacts oocyte quality, a critical factor for successful fertilization and pregnancy. Despite extensive research, the exact mechanisms remain unclear, and further updates are necessary to optimize treatment strategies.

Objectives: This review aims to summarize current evidence regarding the impact of endometriosis on oocyte quality and its subsequent effects on fertility outcomes, particularly in the context of in vitro fertilization (IVF).

Methods: A comprehensive search was conducted in PubMed using the terms "endometriosis AND oocyte quality," "endometriosis AND infertility, and "endometriosis AND IVF." The review included studies published up to July 2024.

Outcome: The review findings indicate that endometriosis may be associated with decreased oocyte quality, characterized by impaired morphological features and molecular abnormalities. These defects potentially lead to lower fertilization rates, impaired embryo development, and reduced pregnancy outcomes. However, some studies suggest that with controlled factors such as age and ovarian reserve, IVF outcomes may be comparable to those without endometriosis.

Conclusions and outlook: For clinicians and scientists working in medically assisted reproduction, understanding the impact of endometriosis on oocyte quality is crucial for improving fertility treatment outcomes. Advances in assisted reproductive technologies and personalized treatment approaches may mitigate these adverse effects. The potential for using artificial intelligence to assess oocyte quality presents a promising avenue for future research, as currently there is no direct and objective measure to assess this parameter.

背景 子宫内膜异位症是一种慢性妇科疾病,影响着全球约 10% 的育龄妇女。由于盆腔疼痛和不孕等症状,子宫内膜异位症的发病率很高。目前的研究表明,子宫内膜异位症会影响卵母细胞质量,而卵母细胞质量是成功受精和怀孕的关键因素。尽管进行了广泛的研究,但确切的机制仍不清楚,因此有必要进一步更新,以优化治疗策略。目的 本综述旨在总结有关子宫内膜异位症对卵母细胞质量的影响及其对生育结果的后续影响的现有证据,尤其是在体外受精(IVF)的情况下。方法 使用 "子宫内膜异位症与卵母细胞质量"、"子宫内膜异位症与不孕症 "和 "子宫内膜异位症与体外受精 "等词在 PubMed 上进行了全面检索。综述包括截至 2024 年 7 月发表的研究。综述结果综述结果表明,子宫内膜异位症可能与卵母细胞质量下降有关,其特征是形态特征受损和分子异常。这些缺陷可能会导致受精率降低、胚胎发育受损和妊娠结局减少。然而,一些研究表明,在控制年龄和卵巢储备等因素的情况下,试管婴儿的结果可能与无子宫内膜异位症的患者相当。结论与展望 对于从事医学辅助生殖的临床医生和科学家来说,了解子宫内膜异位症对卵母细胞质量的影响对于改善生育治疗效果至关重要。辅助生殖技术和个性化治疗方法的进步可能会减轻这些不利影响。使用人工智能评估卵母细胞质量的潜力为未来的研究提供了一个前景广阔的途径,因为目前还没有直接客观的方法来评估这一参数。
{"title":"Oocyte Quality in Women with Endometriosis.","authors":"Rafael Trinchant, Juan Antonio García-Velasco","doi":"10.1159/000541615","DOIUrl":"10.1159/000541615","url":null,"abstract":"<p><strong>Background: </strong>Endometriosis is a chronic gynecological condition that affects approximately 10% of women of reproductive age globally. It is associated with significant morbidity due to symptoms such as pelvic pain and infertility. Current knowledge suggests that endometriosis impacts oocyte quality, a critical factor for successful fertilization and pregnancy. Despite extensive research, the exact mechanisms remain unclear, and further updates are necessary to optimize treatment strategies.</p><p><strong>Objectives: </strong>This review aims to summarize current evidence regarding the impact of endometriosis on oocyte quality and its subsequent effects on fertility outcomes, particularly in the context of in vitro fertilization (IVF).</p><p><strong>Methods: </strong>A comprehensive search was conducted in PubMed using the terms \"endometriosis AND oocyte quality,\" \"endometriosis AND infertility, and \"endometriosis AND IVF.\" The review included studies published up to July 2024.</p><p><strong>Outcome: </strong>The review findings indicate that endometriosis may be associated with decreased oocyte quality, characterized by impaired morphological features and molecular abnormalities. These defects potentially lead to lower fertilization rates, impaired embryo development, and reduced pregnancy outcomes. However, some studies suggest that with controlled factors such as age and ovarian reserve, IVF outcomes may be comparable to those without endometriosis.</p><p><strong>Conclusions and outlook: </strong>For clinicians and scientists working in medically assisted reproduction, understanding the impact of endometriosis on oocyte quality is crucial for improving fertility treatment outcomes. Advances in assisted reproductive technologies and personalized treatment approaches may mitigate these adverse effects. The potential for using artificial intelligence to assess oocyte quality presents a promising avenue for future research, as currently there is no direct and objective measure to assess this parameter.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"1-9"},"PeriodicalIF":2.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142345576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HLTF/SERPINE1 Axis Plays a Crucial Pro-Oncogenic Role in the Progression from Cervical Precancerous Lesions to Cervical Carcinoma in vitro. HLTF/SERPINE1轴在宫颈癌前病变向宫颈癌的体外进展过程中发挥着至关重要的促癌作用
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-30 DOI: 10.1159/000540384
Yong Wang, Yudi Tan, Shasha Yang, Jinkong Wei, Yuying Wei, Junying Chen

Objectives: Cervical carcinoma (CC) is prevalent among women worldwide with increasing risk. Finding effective methods for treating CC is of utmost importance. The aim of this study was to investigate the effect of SERPINE1 on the progression of cervical precancerous lesions to CC.

Design: This study used transcriptome sequencing and in vitro cell line. Participants/Materials: Cervical precancerous lesions and CC samples and human cervical epithelial immortalized cell line H8, human CC cell lines HeLa, and CaSki were involved in this study.

Setting and methods: Next-generation sequencing was applied to identify 100 differentially expressed genes from cervical precancerous lesions and CC samples. With the application of the Search Tool for the Retrieval of Interacting Genes (STRING) database, we carried out the protein-protein interaction network analysis, thus screening out serine protease inhibitor clade E member 1 (SERPINE1) with significant upregulation in CC cells. The helicase-like transcription factor (HLTF) was predicted as the upstream transcription factor using Human Transcription Factor Database (HumanTFDB). The chromatin immunoprecipitation (ChIP) experiment was conducted to validate the interaction between SERPINE1 and HLTF. The immunohistochemistry was employed to determine the expression of SERPINE1 and HLTF in CC tissues. Following the upregulation or downregulation of SERPINE1 and HLTF, the real-time quantitative reverse transcription polymerase chain reaction was carried out to assess mRNA expression levels of SERPINE1 and HLTF in cells. Cell viability, migration, and invasion were evaluated using MTT assay, cell scratch assay, and Transwell assay, respectively. Western blot analysis was conducted to assess changes in the expression levels of matrix metalloproteinases and proteins related to epithelial-mesenchymal transition (EMT).

Results: The ChIP experiment confirmed the interaction between HLTF and SERPINE1. HLTF and SERPINE1 were upregulated in CC tissues and cells, and silencing SERPINE1 inhibited the EMT process and viability, migration, and invasion of CC cells. However, overexpression of SERPINE1 in CC cells showed the opposite trend. Rescue experiments demonstrated that silencing HLTF repressed CC cell viability, migration, and invasion, which could be restored by overexpressing SERPINE1.

Limitations: The effect of the HLTF/SERPINE1 axis on CC malignant progression has not been confirmed by in vivo experiments.

Conclusion: HLTF transcriptionally activates SERPINE1, promoting the progression from cervical precancerous lesions to CC.

目的:宫颈癌(CC)在全球妇女中普遍存在,而且发病风险越来越高。寻找治疗宫颈癌的有效方法至关重要。本研究旨在探讨 SERPINE1 对宫颈癌前病变发展为 CC 的影响:设计:转录组测序和体外细胞系研究。参与者/材料:宫颈癌前病变和CC样本、人宫颈上皮永生细胞系H8、人CC细胞系HeLa和CaSki:应用新一代测序技术从宫颈癌前病变和CC样本中鉴定出100个差异表达基因(DEGs)。应用检索相互作用基因的搜索工具(STRING)数据库,我们进行了蛋白质-蛋白质相互作用(PPI)网络分析,从而筛选出在CC细胞中显著上调的丝氨酸蛋白酶抑制剂E族成员1(SERPINE1)。利用人类转录因子数据库(HumanTFDB)预测了螺旋酶样转录因子(HLTF)作为上游转录因子。染色质免疫共沉淀(ChIP)实验验证了SERPINE1与HLTF之间的相互作用。免疫组织化学(IHC)检测了SERPINE1和HLTF在CC组织中的表达。在上调或下调 SERPINE1 和 HLTF 后,进行实时定量反转录聚合酶链反应(qRT-PCR)以评估细胞中 SERPINE1 和 HLTF 的 mRNA 表达水平。细胞活力、迁移和侵袭分别采用 MTT 试验、细胞划痕试验和 Transwell 试验进行评估。Western印迹(WB)分析评估了基质金属蛋白酶和上皮-间质转化(EMT)相关蛋白表达水平的变化:结果:ChIP实验证实了HLTF和SERPINE1之间的相互作用。HLTF和SERPINE1在CC组织和细胞中上调,沉默SERPINE1可抑制EMT过程和CC细胞的活力、迁移和侵袭。然而,在CC细胞中过表达SERPINE1则表现出相反的趋势。拯救实验表明,沉默HLTF抑制了CC细胞的活力、迁移和侵袭,而过表达SERPINE1则可恢复活力、迁移和侵袭:局限性:HLTF/SERPINE1轴对CC恶性进展的影响尚未得到体内实验的证实:结论:HLTF可转录激活SERPINE1,促进宫颈癌前病变向CC发展。
{"title":"HLTF/SERPINE1 Axis Plays a Crucial Pro-Oncogenic Role in the Progression from Cervical Precancerous Lesions to Cervical Carcinoma in vitro.","authors":"Yong Wang, Yudi Tan, Shasha Yang, Jinkong Wei, Yuying Wei, Junying Chen","doi":"10.1159/000540384","DOIUrl":"10.1159/000540384","url":null,"abstract":"<p><strong>Objectives: </strong>Cervical carcinoma (CC) is prevalent among women worldwide with increasing risk. Finding effective methods for treating CC is of utmost importance. The aim of this study was to investigate the effect of SERPINE1 on the progression of cervical precancerous lesions to CC.</p><p><strong>Design: </strong>This study used transcriptome sequencing and in vitro cell line. Participants/Materials: Cervical precancerous lesions and CC samples and human cervical epithelial immortalized cell line H8, human CC cell lines HeLa, and CaSki were involved in this study.</p><p><strong>Setting and methods: </strong>Next-generation sequencing was applied to identify 100 differentially expressed genes from cervical precancerous lesions and CC samples. With the application of the Search Tool for the Retrieval of Interacting Genes (STRING) database, we carried out the protein-protein interaction network analysis, thus screening out serine protease inhibitor clade E member 1 (SERPINE1) with significant upregulation in CC cells. The helicase-like transcription factor (HLTF) was predicted as the upstream transcription factor using Human Transcription Factor Database (HumanTFDB). The chromatin immunoprecipitation (ChIP) experiment was conducted to validate the interaction between SERPINE1 and HLTF. The immunohistochemistry was employed to determine the expression of SERPINE1 and HLTF in CC tissues. Following the upregulation or downregulation of SERPINE1 and HLTF, the real-time quantitative reverse transcription polymerase chain reaction was carried out to assess mRNA expression levels of SERPINE1 and HLTF in cells. Cell viability, migration, and invasion were evaluated using MTT assay, cell scratch assay, and Transwell assay, respectively. Western blot analysis was conducted to assess changes in the expression levels of matrix metalloproteinases and proteins related to epithelial-mesenchymal transition (EMT).</p><p><strong>Results: </strong>The ChIP experiment confirmed the interaction between HLTF and SERPINE1. HLTF and SERPINE1 were upregulated in CC tissues and cells, and silencing SERPINE1 inhibited the EMT process and viability, migration, and invasion of CC cells. However, overexpression of SERPINE1 in CC cells showed the opposite trend. Rescue experiments demonstrated that silencing HLTF repressed CC cell viability, migration, and invasion, which could be restored by overexpressing SERPINE1.</p><p><strong>Limitations: </strong>The effect of the HLTF/SERPINE1 axis on CC malignant progression has not been confirmed by in vivo experiments.</p><p><strong>Conclusion: </strong>HLTF transcriptionally activates SERPINE1, promoting the progression from cervical precancerous lesions to CC.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"1-12"},"PeriodicalIF":2.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142345575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Hidden Blood Loss between Laparoendoscopic Single-Site Myomectomy and Conventional Laparoscopic Myomectomy. 腹腔镜单部位子宫肌瘤剔除术与传统腹腔镜子宫肌瘤剔除术隐性失血量的比较
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-25 DOI: 10.1159/000539898
Jiayu Tao, Sennan Zhu, Ziqi Chen, Qiuyu Chen, Wenzhuo Du, Jindan Sun, Mengqi Yu, Yi Zhou, Yu Zhao, Qiong Zhang

Objective: Laparoendoscopic single-site myomectomy (LESS-M) is widely applied for the treatment of uterine leiomyoma. The purposes of this study were to investigate differences in hidden blood loss between LESS-M and conventional laparoscopic myomectomy (CLM) during treatment of uterine leiomyoma and to identify the associated risk factors.

Design: This is a retrospective study.

Participants: The participants of this study were patients who underwent laparoscopic myomectomy (114 and 156 for LESS-M and CLM, respectively) between July 1, 2019, and October 10, 2020, at the Second Affiliated Hospital of Wenzhou Medical University.

Setting: The study was conducted at the Second Affiliated Hospital of Wenzhou Medical University.

Methods: We enrolled a total of 114 and 156 patients who were treated with LESS-M and CLM, respectively, between July 1, 2019, and October 10, 2020. We collected clinical data, then applied the Nadler and Gross formula and multiple linear regression analysis to calculate the HBL and identify the associated risk factors, respectively.

Results: Patients in the LESS-M group had a VBL of 115.4 ± 180.6 mL and an HBL of 364.3 ± 252.6 mL, accounting for 74.4 ± 22.4% of true TBL. On the other hand, patients in the CLM group had VBL of 187.9 ± 198.5 mL, and HBL of 306.8 ± 304.7 mL, accounting for 58.9 ± 30.2% of true TBL. HBL was significantly higher in the LESS-M than the CLM group (p = 0.000).

Limitations: This study was the small sample size used.

Conclusions: HBL accounted for a significant percentage of TBL in laparoscopic myomectomy, especially in patients treated with LESS-M. Paying attention to perioperative blood changes coupled with fully understanding HBL might promote postoperative recovery of patients.

目的:腹腔镜单部位子宫肌瘤剔除术(LESS-M)被广泛应用于子宫肌瘤的治疗。本研究旨在探讨 LESS-M 与传统腹腔镜子宫肌瘤剔除术(CLM)在治疗子宫肌瘤过程中隐性失血的差异,并确定相关的风险因素:设计:这是一项回顾性研究:本研究的参与者为2019年7月1日至2020年10月10日期间在温州医科大学附属第二医院接受腹腔镜子宫肌瘤剔除术的患者(LESS-M和CLM分别为114例和156例):研究在温州医科大学附属第二医院进行:在2019年7月1日至2020年10月10日期间,我们分别招募了114名和156名接受LESS-M和CLM治疗的患者。我们收集了临床数据,然后应用纳德勒和格罗斯公式以及多元线性回归分析分别计算了HBL并确定了相关风险因素:LESS-M组患者的VBL为115.4 ± 180.6 mL,HBL为364.3 ± 252.6 mL,占真实TBL的74.4 ± 22.4%。另一方面,CLM 组患者的 VBL 为 187.9 ± 198.5 mL,HBL 为 306.8 ± 304.7 mL,占真实 TBL 的 58.9 ± 30.2%。LESS-M组的HBL明显高于CLM组(P = 0.000):本研究的样本量较小:在腹腔镜子宫肌瘤切除术中,HBL占TBL的很大比例,尤其是在接受LESS-M治疗的患者中。关注围手术期的血液变化并充分了解 HBL 可能会促进患者的术后恢复。
{"title":"Comparison of Hidden Blood Loss between Laparoendoscopic Single-Site Myomectomy and Conventional Laparoscopic Myomectomy.","authors":"Jiayu Tao, Sennan Zhu, Ziqi Chen, Qiuyu Chen, Wenzhuo Du, Jindan Sun, Mengqi Yu, Yi Zhou, Yu Zhao, Qiong Zhang","doi":"10.1159/000539898","DOIUrl":"https://doi.org/10.1159/000539898","url":null,"abstract":"<p><strong>Objective: </strong>Laparoendoscopic single-site myomectomy (LESS-M) is widely applied for the treatment of uterine leiomyoma. The purposes of this study were to investigate differences in hidden blood loss between LESS-M and conventional laparoscopic myomectomy (CLM) during treatment of uterine leiomyoma and to identify the associated risk factors.</p><p><strong>Design: </strong>This is a retrospective study.</p><p><strong>Participants: </strong>The participants of this study were patients who underwent laparoscopic myomectomy (114 and 156 for LESS-M and CLM, respectively) between July 1, 2019, and October 10, 2020, at the Second Affiliated Hospital of Wenzhou Medical University.</p><p><strong>Setting: </strong>The study was conducted at the Second Affiliated Hospital of Wenzhou Medical University.</p><p><strong>Methods: </strong>We enrolled a total of 114 and 156 patients who were treated with LESS-M and CLM, respectively, between July 1, 2019, and October 10, 2020. We collected clinical data, then applied the Nadler and Gross formula and multiple linear regression analysis to calculate the HBL and identify the associated risk factors, respectively.</p><p><strong>Results: </strong>Patients in the LESS-M group had a VBL of 115.4 ± 180.6 mL and an HBL of 364.3 ± 252.6 mL, accounting for 74.4 ± 22.4% of true TBL. On the other hand, patients in the CLM group had VBL of 187.9 ± 198.5 mL, and HBL of 306.8 ± 304.7 mL, accounting for 58.9 ± 30.2% of true TBL. HBL was significantly higher in the LESS-M than the CLM group (p = 0.000).</p><p><strong>Limitations: </strong>This study was the small sample size used.</p><p><strong>Conclusions: </strong>HBL accounted for a significant percentage of TBL in laparoscopic myomectomy, especially in patients treated with LESS-M. Paying attention to perioperative blood changes coupled with fully understanding HBL might promote postoperative recovery of patients.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"1-9"},"PeriodicalIF":2.0,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142345574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endometriosis and infertility: a bibliometric analysis of the 100 most cited articles from 2000 to 2023. 子宫内膜异位症与不孕症:对2000年至2023年被引用次数最多的100篇文章进行文献计量分析。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-20 DOI: 10.1159/000541380
João Pedro Veras Torres, Eduardo Correia Eulálio, Felipe da Costa Oliveira, Gabriel Fontenele Ximenes, Helvécio Neves Feitosa Filho, Leonardo Brito de Souza, Edward Araujo Júnior, Marcelo Cavalcante

Objectives: This study aimed to conduct a bibliometric analysis of research on endometriosis and infertility, focusing on the 100 most cited (TOP100) articles in the literature.

Design: Bibliometric Analysis Participants/Materials, Setting, Methods: The SCOPUS database was searched using the terms "endometriosis" and "infertility." The productivity and impact of research publications by authors, countries, and journals were assessed using the following indicators: total number of publications (TNP), total number of citations (TNC), JIF, and JCI. The bibliometric analysis was conducted from January 1, 2000, to December 31, 2023, using IBM SPSS™ for Windows and VOSviewer 1.6.20. VOSviewer was used to evaluate the TNC, total number of authors/co-authors, and collaboration network between countries of the TOP100 articles. VOSviewer was also used to create keyword co-occurrence networks.

Results: Of the TOP100 articles, 69 were literature review articles, with a mean of 448.97 + 513.5 citations (range: 191 to 2705). The TOP100 articles were published by 479 authors (mean 5.8 + 7.3 per study) from 40 countries in 39 high-impact journals. The keyword co-occurrence network revealed a grouping of four clusters, with terms related to pathophysiology, clinical management, assisted reproductive technology, and hormonal treatment of endometriosis.

Limitations: The main limitation of our study is the use of only one database and TNC as the main bibliometric indicator. Studies need at least 2 to 3 years after publication to accumulate sufficient citations for bibliometric indicators to be reliable. This means that large number of recent studies were not included in this bibliometric analysis.

Conclusions: This study revealed trends in endometriosis and infertility research, especially in the fields of immunology and genetics. It also highlights the importance of global collaboration to improve diagnostics, treatments and outcomes.

目的:本研究旨在对有关子宫内膜异位症和不孕症的研究进行文献计量分析:本研究旨在对有关子宫内膜异位症和不孕症的研究进行文献计量分析,重点关注文献中被引用次数最多的 100 篇文章(TOP100):文献计量分析 参与者/材料、环境、方法:使用 "子宫内膜异位症 "和 "不孕症 "这两个术语在 SCOPUS 数据库中进行检索。使用以下指标评估了作者、国家和期刊发表的研究论文的生产力和影响力:论文总数(TNP)、总被引次数(TNC)、JIF和JCI。文献计量学分析是在 2000 年 1 月 1 日至 2023 年 12 月 31 日期间进行的,使用的是 IBM SPSS™ for Windows 和 VOSviewer 1.6.20。VOSviewer 用于评估 TOP100 文章的 TNC、作者/共同作者总数以及国家间的合作网络。VOSviewer 还用于创建关键词共现网络:在 TOP100 文章中,69 篇为文献综述文章,平均引用次数为 448.97 + 513.5(范围:191 至 2705)。TOP100文章由来自40个国家的479位作者(平均每篇5.8 + 7.3)在39种影响力较大的期刊上发表。关键词共现网络显示出四个群组,术语涉及子宫内膜异位症的病理生理学、临床管理、辅助生殖技术和激素治疗:我们研究的主要局限性在于只使用了一个数据库和 TNC 作为主要的文献计量指标。研究发表后至少需要 2 到 3 年才能积累足够的引文,这样文献计量指标才可靠。这意味着大量近期研究未被纳入文献计量分析:这项研究揭示了子宫内膜异位症和不孕症研究的趋势,尤其是在免疫学和遗传学领域。它还强调了全球合作对于改善诊断、治疗和结果的重要性。
{"title":"Endometriosis and infertility: a bibliometric analysis of the 100 most cited articles from 2000 to 2023.","authors":"João Pedro Veras Torres, Eduardo Correia Eulálio, Felipe da Costa Oliveira, Gabriel Fontenele Ximenes, Helvécio Neves Feitosa Filho, Leonardo Brito de Souza, Edward Araujo Júnior, Marcelo Cavalcante","doi":"10.1159/000541380","DOIUrl":"https://doi.org/10.1159/000541380","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to conduct a bibliometric analysis of research on endometriosis and infertility, focusing on the 100 most cited (TOP100) articles in the literature.</p><p><strong>Design: </strong>Bibliometric Analysis Participants/Materials, Setting, Methods: The SCOPUS database was searched using the terms \"endometriosis\" and \"infertility.\" The productivity and impact of research publications by authors, countries, and journals were assessed using the following indicators: total number of publications (TNP), total number of citations (TNC), JIF, and JCI. The bibliometric analysis was conducted from January 1, 2000, to December 31, 2023, using IBM SPSS™ for Windows and VOSviewer 1.6.20. VOSviewer was used to evaluate the TNC, total number of authors/co-authors, and collaboration network between countries of the TOP100 articles. VOSviewer was also used to create keyword co-occurrence networks.</p><p><strong>Results: </strong>Of the TOP100 articles, 69 were literature review articles, with a mean of 448.97 + 513.5 citations (range: 191 to 2705). The TOP100 articles were published by 479 authors (mean 5.8 + 7.3 per study) from 40 countries in 39 high-impact journals. The keyword co-occurrence network revealed a grouping of four clusters, with terms related to pathophysiology, clinical management, assisted reproductive technology, and hormonal treatment of endometriosis.</p><p><strong>Limitations: </strong>The main limitation of our study is the use of only one database and TNC as the main bibliometric indicator. Studies need at least 2 to 3 years after publication to accumulate sufficient citations for bibliometric indicators to be reliable. This means that large number of recent studies were not included in this bibliometric analysis.</p><p><strong>Conclusions: </strong>This study revealed trends in endometriosis and infertility research, especially in the fields of immunology and genetics. It also highlights the importance of global collaboration to improve diagnostics, treatments and outcomes.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"1-19"},"PeriodicalIF":2.0,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142285879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Protective Effect of Adipose Derived Stromal Vascular Fraction on Ovarian Function in Rats with Cyclophosphamide-Induced Ovarian Damage. 脂肪衍生基质血管组分对环磷酰胺诱发卵巢损伤大鼠卵巢功能的保护作用
IF 2.1 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-12 DOI: 10.1159/000541049
Sabri Berkem Okten,Pinar Ozcan,Olgu Enis Tok,Belgin Devranoglu,Caglar Cetin,Fatma Basak Tanoglu,Cem Ficicioglu
OBJECTIVETo investigate if adipose derived stromal vascular fraction (SVF) treatment has any protective effect on ovarian function in rats with cyclophosphamide (CP) induced ovarian damage.DESIGNExperimental animal study. Participants/ Materials, Setting, Methods: 25 mature cycling Wistar-Albino rats were randomized into four groups (n=5 per group). Rats in Group 1 and 2 received single dose of intraperitoneal (i.p.) 1 mL/kg sodium chloride 0.9% (NaCl). Group 3 and 4 received single dose of 75 mg/kg i.p. CP. On seventh day, SVF was prepared from adipose tissues of 5 additional rats and Group 1 and 3 received 0.9% NaCl i.p. injections while Group 2 and 4 received 0.2 mL i.p. injections of SVF. On day 21 all rats were euthanized, and serum anti-mullerian hormone (AMH) levels, primordial, primary, secondary, antral, and atretic follicle counts, AMH positive staining follicle counts along with AMH staining intensity of the follicles were evaluated.RESULTSAmong two CP induced ovarian damaged groups, SVF treated group showed significantly higher secondary and antral follicle and lower atretic follicle counts, significantly higher mean serum AMH levels, AMH positive antral follicle count and higher intensity of AMH positive follicle scores for primary, secondary and antral follicles when compared to untreated group. Moreover, Group 1 showed no significant difference for all parameters except antral follicle count and AMH positive staining intensity scores for antral follicles when compared to Group 4.LIMITATIONSThis study was conducted on experimental rat model.CONCLUSIONOur study demonstrated a significant protective effect of SVF against Cp-induced ovarian damage which reveals the apparent need for further investigation of its precise mechanisms of action as it may provide a new treatment approach for women with premature ovarian failure.
设计实验性动物研究。参与者/材料、环境和方法:25 只成熟的循环 Wistar-Albino 大鼠被随机分为四组(每组 5 只)。第 1 组和第 2 组大鼠接受单剂量腹腔注射(i.p. )1 mL/kg 0.9% 氯化钠(NaCl)。第 3 组和第 4 组接受单剂量 75 毫克/千克氯化石蜡腹腔注射。第七天,从另外 5 只大鼠的脂肪组织中制备 SVF,第 1 组和第 3 组接受 0.9% 氯化钠静脉注射,第 2 组和第 4 组接受 0.2 mL SVF 静脉注射。第 21 天,对所有大鼠实施安乐死,并评估血清抗苗勒氏管激素(AMH)水平、原始卵泡、初级卵泡、次级卵泡、前区卵泡和闭锁卵泡计数、AMH 阳性染色卵泡计数以及卵泡的 AMH 染色强度。结果在两组 CP 诱导的卵巢损伤中,与未治疗组相比,SVF 治疗组的次级卵泡和喙卵泡数量明显增加,闭锁卵泡数量减少,平均血清 AMH 水平、AMH 阳性喙卵泡数量明显增加,初级卵泡、次级卵泡和喙卵泡的 AMH 阳性卵泡评分强度增加。此外,与第 4 组相比,第 1 组除窦前卵泡计数和窦前卵泡 AMH 阳性染色强度评分外,其他参数均无明显差异。结论我们的研究表明,SVF 对 Cp 引起的卵巢损伤有明显的保护作用,这表明显然需要进一步研究其确切的作用机制,因为它可能为卵巢早衰妇女提供一种新的治疗方法。
{"title":"The Protective Effect of Adipose Derived Stromal Vascular Fraction on Ovarian Function in Rats with Cyclophosphamide-Induced Ovarian Damage.","authors":"Sabri Berkem Okten,Pinar Ozcan,Olgu Enis Tok,Belgin Devranoglu,Caglar Cetin,Fatma Basak Tanoglu,Cem Ficicioglu","doi":"10.1159/000541049","DOIUrl":"https://doi.org/10.1159/000541049","url":null,"abstract":"OBJECTIVETo investigate if adipose derived stromal vascular fraction (SVF) treatment has any protective effect on ovarian function in rats with cyclophosphamide (CP) induced ovarian damage.DESIGNExperimental animal study. Participants/ Materials, Setting, Methods: 25 mature cycling Wistar-Albino rats were randomized into four groups (n=5 per group). Rats in Group 1 and 2 received single dose of intraperitoneal (i.p.) 1 mL/kg sodium chloride 0.9% (NaCl). Group 3 and 4 received single dose of 75 mg/kg i.p. CP. On seventh day, SVF was prepared from adipose tissues of 5 additional rats and Group 1 and 3 received 0.9% NaCl i.p. injections while Group 2 and 4 received 0.2 mL i.p. injections of SVF. On day 21 all rats were euthanized, and serum anti-mullerian hormone (AMH) levels, primordial, primary, secondary, antral, and atretic follicle counts, AMH positive staining follicle counts along with AMH staining intensity of the follicles were evaluated.RESULTSAmong two CP induced ovarian damaged groups, SVF treated group showed significantly higher secondary and antral follicle and lower atretic follicle counts, significantly higher mean serum AMH levels, AMH positive antral follicle count and higher intensity of AMH positive follicle scores for primary, secondary and antral follicles when compared to untreated group. Moreover, Group 1 showed no significant difference for all parameters except antral follicle count and AMH positive staining intensity scores for antral follicles when compared to Group 4.LIMITATIONSThis study was conducted on experimental rat model.CONCLUSIONOur study demonstrated a significant protective effect of SVF against Cp-induced ovarian damage which reveals the apparent need for further investigation of its precise mechanisms of action as it may provide a new treatment approach for women with premature ovarian failure.","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":"28 1","pages":"1-13"},"PeriodicalIF":2.1,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142269112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Value of Human Epididymal Protein 4, Carcinoembryonic Antigen and Alpha-Fetoprotein in the Early Diagnosis of Cervical Cancer. 人类附睾蛋白 4、癌胚抗原和甲胎蛋白在宫颈癌早期诊断中的价值。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-30 DOI: 10.1159/000540855
Xiaoyan Ye, Shanyan Xie

Objectives: This research aimed to unveil the value of human epididymal protein 4 (HE4), carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in the early diagnosis of cervical cancer.

Design: This was a clinical study.

Participants: Sixty patients with cervical cancer stage IA-IIA (early stage cervical cancer group), 60 patients with cervical intraepithelial neoplasia (CIN) (disease control group), and 60 healthy women who had passed the physical examination (healthy control group) were selected.

Setting: The review was conducted in a Jiaxing First Hospital.

Methods: Sixty patients with cervical cancer stage IA-IIA (early stage cervical cancer group), 60 patients with CIN (disease control group), and 60 healthy women who had passed the physical examination (healthy control group) were selected. The expression levels of serum HE4, CEA, and AFP in the three groups were detected, and the correlation between the levels of serum HE4, CEA, and AFP and the clinicopathological characteristics of patients with early stage cervical cancer were analyzed, and the receiver operating characteristic (ROC) curves were plotted to identify the value of the single and triple tests of serum HE4, CEA, and AFP for the early stage diagnosis of cervical cancer.

Results: The levels of serum HE4, CEA, and AFP in the early stage cervical cancer group were higher than those in the disease control and the healthy control groups (p < 0.05). The levels of serum HE4, CEA, and AFP were related to the FIGO stage as well as the histological grading of patients with early stage cervical cancer (p < 0.05). The results of the ROC curves revealed that the AUC areas of HE4, CEA, and AFP for single as well as triple diagnosis of patients with early stage cervical cancer were 0.725, 0.679, 0.663, and 0.811, respectively, and the AUC of the three combined tests was markedly higher than that of HE4, CEA, AFP single test (p < 0.05).

Limitations: There is a lack of larger sample sizes to test whether the combined HE4, CEA, and AFP detection has sufficient validity at the individual level and there are not enough serum samples in this study to perform circulating HPV-DNA detection and compare it with the levels of serum markers.

Conclusion: The combination of HE4, CEA, and AFP has good clinical reference value analysis in the auxiliary diagnosis of early stage cervical cancer, and it is worthy of further validation and popularization.

研究目的本研究旨在揭示人附睾蛋白 4 (HE4)、癌胚抗原 (CEA) 和甲胎蛋白 (AFP) 在宫颈癌早期诊断中的价值:临床研究 参与者选择60例IA-IIA期宫颈癌患者(早期宫颈癌组)、60例宫颈上皮内瘤变(CIN)患者(疾病对照组)和60例体检合格的健康女性(健康对照组):嘉兴市第一医院 方法选取60例IA-IIA期宫颈癌患者(早期宫颈癌组)、60例宫颈上皮内瘤变(CIN)患者(疾病对照组)和60例体检合格的健康女性(健康对照组)。检测三组患者血清HE4、CEA和AFP的表达水平,分析血清HE4、CEA和AFP水平与早期宫颈癌患者临床病理特征的相关性,绘制ROC曲线,以确定血清HE4、CEA和AFP单项检测和三项检测对宫颈癌早期诊断的价值:结果:早期宫颈癌组血清HE4、CEA和AFP水平均高于疾病对照组和健康对照组(P< 0.05)。血清 HE4、CEA 和 AFP 水平与早期宫颈癌患者的 FIGO 分期和组织学分级有关(P < 0.05)。ROC曲线结果显示,HE4、CEA和AFP对早期宫颈癌患者的单项诊断和三项诊断的AUC值分别为0.725、0.679、0.663和0.811,三项联合检测的AUC值明显高于HE4、CEA和AFP单项检测的AUC值(P <0.05):局限性:缺乏更大的样本量来检验HE4、CEA和AFP联合检测在个体水平上是否具有足够的有效性,而且本研究中没有足够的血清样本来进行循环HPV DNA检测并与血清标志物水平进行比较:结论:HE4、CEA和AFP联合检测在早期宫颈癌辅助诊断中具有良好的临床参考价值分析,值得进一步验证和推广。
{"title":"The Value of Human Epididymal Protein 4, Carcinoembryonic Antigen and Alpha-Fetoprotein in the Early Diagnosis of Cervical Cancer.","authors":"Xiaoyan Ye, Shanyan Xie","doi":"10.1159/000540855","DOIUrl":"10.1159/000540855","url":null,"abstract":"<p><strong>Objectives: </strong>This research aimed to unveil the value of human epididymal protein 4 (HE4), carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in the early diagnosis of cervical cancer.</p><p><strong>Design: </strong>This was a clinical study.</p><p><strong>Participants: </strong>Sixty patients with cervical cancer stage IA-IIA (early stage cervical cancer group), 60 patients with cervical intraepithelial neoplasia (CIN) (disease control group), and 60 healthy women who had passed the physical examination (healthy control group) were selected.</p><p><strong>Setting: </strong>The review was conducted in a Jiaxing First Hospital.</p><p><strong>Methods: </strong>Sixty patients with cervical cancer stage IA-IIA (early stage cervical cancer group), 60 patients with CIN (disease control group), and 60 healthy women who had passed the physical examination (healthy control group) were selected. The expression levels of serum HE4, CEA, and AFP in the three groups were detected, and the correlation between the levels of serum HE4, CEA, and AFP and the clinicopathological characteristics of patients with early stage cervical cancer were analyzed, and the receiver operating characteristic (ROC) curves were plotted to identify the value of the single and triple tests of serum HE4, CEA, and AFP for the early stage diagnosis of cervical cancer.</p><p><strong>Results: </strong>The levels of serum HE4, CEA, and AFP in the early stage cervical cancer group were higher than those in the disease control and the healthy control groups (p &lt; 0.05). The levels of serum HE4, CEA, and AFP were related to the FIGO stage as well as the histological grading of patients with early stage cervical cancer (p &lt; 0.05). The results of the ROC curves revealed that the AUC areas of HE4, CEA, and AFP for single as well as triple diagnosis of patients with early stage cervical cancer were 0.725, 0.679, 0.663, and 0.811, respectively, and the AUC of the three combined tests was markedly higher than that of HE4, CEA, AFP single test (p &lt; 0.05).</p><p><strong>Limitations: </strong>There is a lack of larger sample sizes to test whether the combined HE4, CEA, and AFP detection has sufficient validity at the individual level and there are not enough serum samples in this study to perform circulating HPV-DNA detection and compare it with the levels of serum markers.</p><p><strong>Conclusion: </strong>The combination of HE4, CEA, and AFP has good clinical reference value analysis in the auxiliary diagnosis of early stage cervical cancer, and it is worthy of further validation and popularization.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"1-8"},"PeriodicalIF":2.0,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142106887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Diagnostic Reliability of Intraoperative Frozen Section in the Surgical Management of Early-Stage Cervical Cancer. 术中冰冻切片在早期宫颈癌手术治疗中的有效性和诊断可靠性。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-27 DOI: 10.1159/000541096
Sarah Louise Smyth, Edward Jackson, Negin Sadeghi, Christina Pappa, Nahid Ghanbarzadeh, Ciro Pinelli, Pathiraja Pubudu, Sunanda Dhar, Zoe Traill, Pietro Serra, Antonio Simone Laganà, Moiad Alazzam

Objectives: The aim of this study of this study was to evaluate preoperative radiology and histopathology findings in cervical cancer lymphadenopathy detection, allowing targeted frozen section examination (FSE).

Design: A retrospective analysis was conducted of 203 early-stage cervical cancer patients between 2010 and 2019 in a tertiary centre.

Participants/materials, setting, and methods: All patients had histologically confirmed cervical cancer and underwent magnetic resonance imaging (MRI) prior to intraoperative FSE. The primary objectives of the study were to determine the diagnostic accuracy of intraoperative FSE in the identification of lymph node metastases (LNM) in early-stage cervical cancer by correlation with final results obtained using standard histopathology techniques and to examine different preoperative, intraoperative, demographic, radiological, and histopathological factors that could identify those at greatest risk of nodal disease and hence predict those most likely to benefit from FSE, enabling more selective and targeted use.

Results: Nineteen patients were found to have LNM (9.36%) at FSE. Patients were at increased risk of LNM by 6-fold with positive LVSI, 3-fold with MRI lymphadenopathy, and 3.5-fold with MRI-visible disease. The presence of lymphadenopathy on MRI and positive LVSI in combination increased the risk of LNM by 19-fold.

Limitations: We acknowledge that FSE is expensive and time intensive, exposing patients to increased surgery duration and associated risk. We also recognize that it may not be feasible for all patients. Finally, the analysis is limited by retrospective nature of the study.

Conclusions: By application of the preoperative risk stratification algorithm, we may suggest that FSE can be a useful tool in high-risk patients.

目的:评估宫颈癌淋巴结病检测中的术前放射学和组织病理学发现:评估宫颈癌淋巴结病检测的术前放射学和组织病理学结果,以便进行有针对性的冰冻切片检查(FSE):对一家三级医疗中心2010年至2019年间的203例早期宫颈癌患者进行回顾性分析:所有患者均经组织学确诊为宫颈癌,并在术中 FSE 之前接受了磁共振成像(MRI)检查。研究的主要目的是:通过与使用标准组织病理学技术获得的最终结果的相关性,确定术中 FSE 在早期宫颈癌淋巴结转移(LNM)鉴定中的诊断准确性,并研究不同的术前、术中、人口学、放射学和组织病理学因素,这些因素可以确定哪些患者最有可能发生结节病,从而预测哪些患者最有可能从 FSE 中获益,使 FSE 的使用更具选择性和针对性:19 名患者在进行 FSE 检查时被发现患有 LNM(9.36%)。LVSI 阳性患者的 LNM 风险增加了 6 倍,MRI 淋巴结病增加了 3 倍,MRI 可见疾病增加了 3.5 倍。MRI 淋巴结病和 LVSI 阳性同时存在会使 LNM 风险增加 19 倍:我们认识到,FSE 费用昂贵且不可预测地耗费时间,使患者面临更长的手术时间和相关风险。我们也认识到,并非所有患者都能接受 FSE。最后,研究的回顾性也限制了分析的进行:通过应用术前风险分层算法,我们认为 FSE 对高风险患者来说是一种有用的工具。
{"title":"Efficacy and Diagnostic Reliability of Intraoperative Frozen Section in the Surgical Management of Early-Stage Cervical Cancer.","authors":"Sarah Louise Smyth, Edward Jackson, Negin Sadeghi, Christina Pappa, Nahid Ghanbarzadeh, Ciro Pinelli, Pathiraja Pubudu, Sunanda Dhar, Zoe Traill, Pietro Serra, Antonio Simone Laganà, Moiad Alazzam","doi":"10.1159/000541096","DOIUrl":"10.1159/000541096","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study of this study was to evaluate preoperative radiology and histopathology findings in cervical cancer lymphadenopathy detection, allowing targeted frozen section examination (FSE).</p><p><strong>Design: </strong>A retrospective analysis was conducted of 203 early-stage cervical cancer patients between 2010 and 2019 in a tertiary centre.</p><p><strong>Participants/materials, setting, and methods: </strong>All patients had histologically confirmed cervical cancer and underwent magnetic resonance imaging (MRI) prior to intraoperative FSE. The primary objectives of the study were to determine the diagnostic accuracy of intraoperative FSE in the identification of lymph node metastases (LNM) in early-stage cervical cancer by correlation with final results obtained using standard histopathology techniques and to examine different preoperative, intraoperative, demographic, radiological, and histopathological factors that could identify those at greatest risk of nodal disease and hence predict those most likely to benefit from FSE, enabling more selective and targeted use.</p><p><strong>Results: </strong>Nineteen patients were found to have LNM (9.36%) at FSE. Patients were at increased risk of LNM by 6-fold with positive LVSI, 3-fold with MRI lymphadenopathy, and 3.5-fold with MRI-visible disease. The presence of lymphadenopathy on MRI and positive LVSI in combination increased the risk of LNM by 19-fold.</p><p><strong>Limitations: </strong>We acknowledge that FSE is expensive and time intensive, exposing patients to increased surgery duration and associated risk. We also recognize that it may not be feasible for all patients. Finally, the analysis is limited by retrospective nature of the study.</p><p><strong>Conclusions: </strong>By application of the preoperative risk stratification algorithm, we may suggest that FSE can be a useful tool in high-risk patients.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"1-14"},"PeriodicalIF":2.0,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142080130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Mechanical Bowel Preparation before Robot-Assisted Laparoscopic Gynecologic Surgery: A Randomized, Single-Blind, Controlled Trial. 机器人辅助腹腔镜妇科手术前机械肠道准备的效果:随机、单盲、对照试验。
IF 2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-26 DOI: 10.1159/000541095
Hyonjee Yoon, Jung Hyun Park, Jisu Mun, Youngjae Yoon, Jin-Ju Lee, Minji Ko, Hyun-Hee Cho, Jeong Namkung

Objective: The objective of this randomized controlled trial was to compare the effect of bowel preparation using only oral polyethylene glycol electrolyte (PEG) solution versus oral PEG solution combined with mechanical sodium phosphate (NaP) enema on the surgical field visualization in patients undergoing robot-assisted laparoscopic gynecologic procedures.

Methods: Participants were randomized to either a single oral PEG solution or an oral PEG solution combined by mechanical NaP enema. The intraoperative visualization of the surgical field, the ease of manipulation of the bowels, and overall difficulty level of the surgery were evaluated by the surgeon using a self-administered questionnaire. After the surgery, the patients completed a survey assessing postoperative gastrointestinal discomfort.

Results: A total of 114 women were enrolled and randomized to oral PEG solution-only group (n = 48), and oral PEG plus mechanical NaP enema group (n = 66). Forty-two women in oral PEG-only group and 59 oral PEG plus NaP enema group completed the study. There was no difference in intraoperative visualization or overall difficulty of the operation between the two groups, and bowel manipulation was easier in the oral PEG-only group. Also, there was no difference in operating time between the groups. The patients' level of gastrointestinal discomfort after the surgery was not significantly different between the two groups.

Conclusion: Routine use of mechanical NaP enema before robot-assisted laparoscopic gynecologic surgery is not recommended, because it has no additional benefit regarding intraoperative visualization or the surgical level of difficulty over oral bowel preparation methods.

试验目的这项随机对照试验的目的是比较仅口服聚乙二醇电解质(PEG)溶液与口服聚乙二醇电解质溶液(PEG)联合机械磷酸钠(NaP)灌肠对接受机器人辅助腹腔镜妇科手术的患者手术视野的影响:方法:参与者被随机分配到单一口服PEG溶液或口服PEG溶液联合机械NaP灌肠。外科医生使用自制问卷对术中手术视野的可视性、肠道操作的难易程度以及手术的整体难度进行评估。术后,患者填写了一份评估术后胃肠道不适的调查表:114 名妇女入选并随机分为仅口服 PEG 溶液组(48 人)和口服 PEG 加机械 NaP 灌肠组(66 人)。仅口服 PEG 组 42 名妇女和口服 PEG 加 NaP 灌肠组 59 名妇女完成了研究。两组在术中可视化或整体手术难度方面没有差异,仅口服 PEG 组的肠道操作更容易。此外,两组的手术时间也没有差异。两组患者术后胃肠道不适程度无明显差异:结论:不建议在机器人辅助腹腔镜妇科手术前常规使用机械NaP灌肠,因为与口服肠道准备方法相比,机械NaP灌肠在术中可视化或手术难度方面没有额外的益处。
{"title":"Effectiveness of Mechanical Bowel Preparation before Robot-Assisted Laparoscopic Gynecologic Surgery: A Randomized, Single-Blind, Controlled Trial.","authors":"Hyonjee Yoon, Jung Hyun Park, Jisu Mun, Youngjae Yoon, Jin-Ju Lee, Minji Ko, Hyun-Hee Cho, Jeong Namkung","doi":"10.1159/000541095","DOIUrl":"10.1159/000541095","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this randomized controlled trial was to compare the effect of bowel preparation using only oral polyethylene glycol electrolyte (PEG) solution versus oral PEG solution combined with mechanical sodium phosphate (NaP) enema on the surgical field visualization in patients undergoing robot-assisted laparoscopic gynecologic procedures.</p><p><strong>Methods: </strong>Participants were randomized to either a single oral PEG solution or an oral PEG solution combined by mechanical NaP enema. The intraoperative visualization of the surgical field, the ease of manipulation of the bowels, and overall difficulty level of the surgery were evaluated by the surgeon using a self-administered questionnaire. After the surgery, the patients completed a survey assessing postoperative gastrointestinal discomfort.</p><p><strong>Results: </strong>A total of 114 women were enrolled and randomized to oral PEG solution-only group (n = 48), and oral PEG plus mechanical NaP enema group (n = 66). Forty-two women in oral PEG-only group and 59 oral PEG plus NaP enema group completed the study. There was no difference in intraoperative visualization or overall difficulty of the operation between the two groups, and bowel manipulation was easier in the oral PEG-only group. Also, there was no difference in operating time between the groups. The patients' level of gastrointestinal discomfort after the surgery was not significantly different between the two groups.</p><p><strong>Conclusion: </strong>Routine use of mechanical NaP enema before robot-assisted laparoscopic gynecologic surgery is not recommended, because it has no additional benefit regarding intraoperative visualization or the surgical level of difficulty over oral bowel preparation methods.</p>","PeriodicalId":12952,"journal":{"name":"Gynecologic and Obstetric Investigation","volume":" ","pages":"1-7"},"PeriodicalIF":2.0,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gynecologic and Obstetric Investigation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1